The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.
Barkovskaya N.A.
Privolzhsky Research Medical University;
Dzerzhinsk Perinatal Center
Shifman E.M.
Moscow Regional Research and Clinical Institute
Katkova N.Yu.
Privolzhsky Research Medical University
Efficacy of erythropoietin combined with intravenous iron therapy for postpartum anemia: a systematic review and meta-analysis of randomized controlled trials
Journal: Russian Journal of Anesthesiology and Reanimatology. 2023;(2): 15‑26
Views: 24002
Downloaded: 188
To cite this article:
Barkovskaya NA, Shifman EM, Katkova NYu. Efficacy of erythropoietin combined with intravenous iron therapy for postpartum anemia: a systematic review and meta-analysis of randomized controlled trials. Russian Journal of Anesthesiology and Reanimatology.
2023;(2):15‑26. (In Russ.)
https://doi.org/10.17116/anaesthesiology202302115
There are few and contradictory data on effectiveness of erythropoietin combined with intravenous iron therapy for postpartum anemia.
To assess the effectiveness of therapy and the need for blood transfusion when using erythropoietin and intravenous iron therapy compared to intravenous iron monotherapy in correction of iron deficiency postpartum anemia.
We analyzed the MEDLINE, Scopus, EBSCOhost and other databases regarding randomized controlled trials (RCTs) investigating erythropoietin combined with intravenous iron therapy vs. intravenous iron therapy alone for postpartum anemia. Primary endpoints: hematological response (changes in hemoglobin concentration, hemoglobin level, ferritin), number of blood transfusions. Secondary endpoints: level of endogenous erythropoietin, soluble transferrin receptors, C-reactive protein, number of adverse reactions. The data were summarized in accordance with the Cochrane guidelines (PRISMA 2020).
The review included two RCTs involving 90 women. One RCT enrolled multiple groups and two erythropoietin dosing regimens. Erythropoietin combined with intravenous iron therapy resulted significant difference in hemoglobin concentration at baseline and 2 weeks later compared to the control group (MD=3.49 (95% CI 0.55-6.43) g/l; p=0.02) (low-quality evidence (GRADE) due to risk of bias and inconsistency). After 1 week, there was no significant between-group difference (MD=2.71 (95% CI –0.52-5.95 g/l; p=0.10) (moderate-quality evidence due to risk of bias). We found no significant differences between cumulative means of hemoglobin concentration and secondary endpoints between groups after 2-week therapy.
We observed significant positive effect of erythropoietin on hemoglobin level after 2-week therapy in women with postpartum anemia. The effect of erythropoietin on transfusion requirements could not be assessed due to few data. Further randomized controlled trials of larger samples are required.
Keywords:
Authors:
Barkovskaya N.A.
Privolzhsky Research Medical University;
Dzerzhinsk Perinatal Center
Shifman E.M.
Moscow Regional Research and Clinical Institute
Katkova N.Yu.
Privolzhsky Research Medical University
Received:
15.01.2023
Accepted:
29.01.2023
List of references:
Close metadata
Email Confirmation
An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.
Email Confirmation
Log in to the site using your account in one of the services
We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.